Array Biopharma, Inc. (ARRY) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.54 +6.75%
EPS Growth %: -48.0%
Financial Fact:
Net loss: -28.61M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -48.0%
Financial Fact:
Net loss: -28.61M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
On Monday, Array Biopharma, Inc. (NASDAQ: ARRY) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $16.7 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- C.H. Robinson acquires DeSpir Logistics for $75 million
- MP Materials seen largely insulated after China export-control move
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
